FDA Clearance Tracker · P980031-S013
INTACS PRESCRIPTION INSERTS/INTACS CORNEAL IMPLANTS
Last checked: Nov 20, 2026Latest source record: Sep 9, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Sep 9, 2024
Approved
Time to decision
343 days
Received Oct 2, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P980031-S013
- Device name
- INTACS PRESCRIPTION INSERTS/INTACS CORNEAL IMPLANTS
- Applicant
- Addition Technology
- Applicant location
- Lombard, IL
- Received
- Oct 2, 2023
- Decided
- Sep 9, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P980031
Device type
- Device type
- Implant, corneal, refractive (LQE)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at AJL Ophthalmic, S.A., Ferdinand Zeppelin 1, Parque Tecnologico Alava, 01510 Minano, Araba, Spain, for manufacturing segment components, inspection, cleaning and primary packaging and sterilization of INTACS Corneal Implants
Source documents
Other decisions for Addition Technology
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.